Gene · 1237
NIH grants1,226
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,226
Download this page as JSON| Grant | Title | CCR8 papers | Newest fiscal year |
|---|---|---|---|
| R01CA124515 | Crosstalk between butyrophilins and gamma delta T cells in human cancer | 1 | 2025 |
| R01CA163217 | Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma | 1 | 2025 |
| R01CA172310 | Novel Targeted Anticancer Agents from Marine Cyanobacteria | 1 | 2025 |
| R01CA241752 | Targeting MUC5AC mucin in breast cancer brain metastasis | 1 | 2025 |
| R01CA249528 | Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance | 1 | 2025 |
| R01CA255153 | THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS | 1 | 2025 |
| R01CA260239 | Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis | 1 | 2025 |
| R01CA266446 | The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy | 1 | 2025 |
| R01DA038446 | 5-HT2 Receptor Allosterism in Cocaine Use Disorder | 1 | 2025 |
| R01DK085252 | Extracellular Matrix Regulates Hepatic Stellate Cell Activation and Fibrosis | 1 | 2025 |
| R01DK106191 | The CD226 costimulatory axis in type 1 diabetes | 1 | 2025 |
| R01DK110352 | Mechanisms associated with flares and remission in colitis | 1 | 2025 |
| R01GM057761 | Structures and Interactions of Chemokine Receptors | 1 | 2025 |
| R01GM122798 | Biasing CXCR3 Signaling to Modulate the Inflammatory Response | 1 | 2025 |
| R01HL065095 | Regulators of immune complex mediated neutrophil antigen presentation | 1 | 2025 |
| R01HL105427 | Role of IL-17 in Protective Vaccine-induced Immune Responses Against Tuberculosis | 1 | 2025 |
| R01HL117913 | The NOTCH Signaling Pathway in Large Vessel Vasculitis | 1 | 2025 |
| R01HL127349 | Genomic Analysis of Tissue and Cellular Heterogeneity in IPF | 1 | 2025 |
| R01HL142068 | T Cell Immunity in Giant Cell Arteritis | 1 | 2025 |
| R01LM013763 | Investigation of the landscape of immunosequencing and its clinical relevance through novel immunoinformatic approaches | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/grants?page=6